norethindrone has been researched along with hrp 102 in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.06) | 18.7374 |
| 1990's | 15 (45.45) | 18.2507 |
| 2000's | 8 (24.24) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Sayed, WS; Darwish, EA; el-Habashy, MA; Haiba, NA; Nayel, SE; Said, SA | 1 |
| Aedo, AR; Diczfalusy, E; Johannisson, E; Landgren, BM | 1 |
| Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 2 |
| Bassol, S; Hernandez, C; Luz de la Cruz, D; Nava, MP; Trujillo, AM | 1 |
| v Kesserü, E | 1 |
| Toppozada, MK | 1 |
| Günzel, P; Seibert, B | 1 |
| Sang, GW | 1 |
| Koetsawang, S | 1 |
| el-Hussein, M; el-Nahal, N; Hassan, EO | 1 |
| Bastianelli, C; Benagiano, G; Bianchi, P; Medda, E; Primiero, FM | 1 |
| el Houssinie, M; el Nahal, N; Hassan, EO | 1 |
| el-Hussinie, M; el-Nahal, N; Hassan, EO | 1 |
| Albrecht, G; Arboleda, C; Bailon, R; Bassol, S; Bucheli, R; Carneiro de Oliveira, H; Carranza, S; Castañeda, A; Celis, C; Chada, E; Cravioto, MC; de Andrade, ME; de Mello, NR; de Melo, K; Durand, M; Fugarolas, J; Gaona, R; Garza-Flores, J; Gomez, P; Gurucharri, C; Hidalgo, I; Lopez, C; Mendez, J; Novelli, J; Olavide, R; Parada, LM; Parejarios, J; Reyes-Marquez, R; Santoyo, S; Succar, J; Trujillo, L; Vazquez, L; Yassle, ME | 1 |
| Beier, S; Etchepareborda, JJ; von Kesserü, E; Wikinski, R | 1 |
| Betkowska-Korpała, B; Czarnecka, D; Jankowski, P; Kawecka-Jaszcz, K; Klocek, M; Olszanecka, A | 1 |
| Cacciatore, B; Hasselblatt, R; Nieminen, MS; Paakkari, I; Tikkanen, MI; Toivonen, J; Ylikorkala, O | 1 |
| Bulent Tiras, M; Darney, PD; Fener, N; Guner, H; Noyan, V; Yildirim, M | 1 |
| Czarnecka, D; Jankowski, P; Kawecka-Jaszcz, K; Olszanecka, A; Rajzer, M | 1 |
| Strandberg, TE; Tikkanen, MJ; Ylikorkala, O | 1 |
| Dahm, AE; Eilertsen, AL; Goeman, J; Kierulf, P; Mowinckel, MC; Olstad, OK; Ovstebø, R; Sandset, PM; Skretting, G | 1 |
| Atabekoğlu, CS; Berker, B; Cengiz, SD; Koçbulut, E; Özmen, B; Sönmezer, M; Şükür, YE; Taşçı, T | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR | 1 |
| Graff-Iversen, S; Hofvind, S; Román, M; Sakshaug, S; Ursin, G; Vangen, S; Weiderpass, E | 1 |
| Fawkes, N; Gotteland, JP; Loumaye, E; Marchand, L; Pohl, O | 1 |
| Gray, S | 1 |
| A R, S; Al Hendy, A; Ali, M | 1 |
7 review(s) available for norethindrone and hrp 102
| Article | Year |
|---|---|
[New perspectives for injectable contraceptives].
Topics: Adolescent; Adult; Aniline Compounds; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipid Metabolism; Norethindrone; Pregnancy | 1994 |
Existing once-a-month combined injectable contraceptives.
Topics: Algestone Acetophenide; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Combinations; Estradiol; Humans; Injections, Intramuscular; Neoplasms, Experimental; Norethindrone; Risk Factors | 1994 |
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; World Health Organization | 1993 |
Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Topics: Animals; Drug Combinations; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Menorrhagia; Norethindrone; Premenopause; Pyrimidines; Uterine Neoplasms | 2021 |
19 trial(s) available for norethindrone and hrp 102
| Article | Year |
|---|---|
Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone | 1989 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone | 1995 |
A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrone; Female; Glucuronates; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Mexico; Norethindrone; Ovulation; Pregnanediol | 1995 |
Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Topics: Attitude; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Egypt; Estradiol; Female; Humans; Marriage; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Retrospective Studies; Surveys and Questionnaires | 1994 |
Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Glucose Clamp Technique; Humans; Lipids; Norethindrone; Pregnancy; Triglycerides | 1997 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank,
Topics: Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Injections; Lipids; Lipoproteins; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Triglycerides | 1997 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Sp
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; gamma-Glutamyltransferase; Glucose Tolerance Test; Humans; Injections; Liver; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone | 1998 |
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain | 1999 |
Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections; Latin America; Norethindrone; Pregnancy; Uterine Hemorrhage; Weight Gain | 2000 |
Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns.
Topics: Adult; Argentina; Biopsy; Bone Density; Contraceptive Agents, Female; Drug Combinations; Endometrium; Estradiol; Female; Humans; Hyperplasia; Injections; Intrauterine Devices; Lipids; Middle Aged; Norethindrone; Patient Satisfaction; Pregnancy; Premenopause; Uterine Hemorrhage | 2000 |
[Influence of hormone replacement therapy on the quality of life in postmenopausal women with hypertension].
Topics: Adipose Tissue; Body Mass Index; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Hemodynamics; Humans; Hypertension; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Quality of Life; Surveys and Questionnaires | 2000 |
Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Prospective Studies; Statistics, Nonparametric | 2001 |
Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters.
Topics: Adolescent; Adult; Bilirubin; Blood Coagulation; Cholesterol; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Fibrinogen; Humans; Injections; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menstruation; Norethindrone; Partial Thromboplastin Time; Prothrombin Time; Serum Albumin; Triglycerides | 2001 |
Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Middle Aged; Norethindrone; Reference Values; Risk Factors | 2003 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
Topics: Aged; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride | 2012 |
Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Topics: Administration, Cutaneous; Administration, Oral; Chemokine CCL2; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Norethindrone; Postmenopause | 2014 |
Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109.
Topics: Administration, Oral; Adult; Bone and Bones; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Healthy Volunteers; Hormone Antagonists; Humans; Menstruation; Middle Aged; Norethindrone; Organic Chemicals; Receptors, LHRH; Young Adult | 2018 |
7 other study(ies) available for norethindrone and hrp 102
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Female; Humans; Injections; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Ovulation; Progesterone | 1985 |
Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Counseling; Drug Combinations; Egypt; Estradiol; Female; Focus Groups; Humans; Islam; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Social Support | 1999 |
The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
Topics: Age Factors; Aged; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Norethindrone; Sex Factors; Time Factors; Vascular Patency | 2002 |
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?
Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction | 2015 |
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar | 2015 |
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
Topics: Aged; Breast Neoplasms; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Risk | 2016 |
Tales from the clinic.
Topics: Aged; Body Temperature Regulation; Brain Stem Infarctions; Drug Combinations; Estradiol; Fatigue; Female; Hormone Replacement Therapy; Humans; Norethindrone; Photophobia; Postmenopause; Postural Balance; Referral and Consultation; Transdermal Patch | 2019 |